[1]
K. Bally, R. Buechel, P. Buser, B. Martina, P. Tschudi, and A. Zeller, “Discontinuation of secondary prevention medication after myocardial infarction – the role of general practitioners and patients”, Swiss Med Wkly, vol. 143, no. 4546, p. w13896, Nov. 2013.